Heparin for the Treatment of Burn Wound Pain
Second Degree Burns
About this trial
This is an interventional treatment trial for Second Degree Burns focused on measuring second degree burns, heparin, topical
Eligibility Criteria
Inclusion Criteria:
- Either gender with age limits 14-60 years.
- 2nd degree burn with Total burn surface area (TBSA) <20% (assessed by Wallace rule of nine) including front of chest and abdomen, upper limbs excluding hands and lower limbs excluding foot.
- Flame and scald burn (on history).
Exclusion Criteria:
- Third degree (painless, lathery eschar with no blanching) and Fourth degree burns (full thickness burn with exposed muscle, tendons or bones) as assessed clinically.
- Chemical or electrical burn (on history).
- Personal or family history of hemorrhagic diathesis, heparin intolerance, any medical illness causing bleeding episodes(e.g, Esophageal varices) or active bleeding from any site.
- History of Liver disease (Total Bilirubin <20umol/L, Alanine amino transferase <36u/L, Aspartate amino transferase <42u/L), or renal disorder (Serum Urea=20-40mg/dl, Serum Creatinine <1.2).
Sites / Locations
- Department of Plastic Surgery, Mayo Hospital, King Edward Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Polyfax & Lignocain gel or silvazine cream
Topical heparin
Polyfax skin ointment plus Lignocain gel will be applied on superficial PTB area and silver sulphadiazine cream on deep PTB in morning and evening after wound wash
Heparin solution (5000 IU/ml) will be sprinkled aseptically on burn surface twice a day for the first 2 days, by "#27" needle connected via drip set to the drip containing heparin aqueous saline. The dose will be reduced to 75% of day 1 on day 3 and 4 and to 50% on day 5. Administration of heparin saline solution will be in 3 cycles with 5-10 minutes interval.